1. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies?
2. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis
3. Abdel Aziz, M. T., H. M. Atta, N. K. Roshdy, L. A. Rashed, D. Sabry, A. A. Hassouna, G. I. Aboul Fotouh, N. M. Hasan, R. H. Younis, and J. R. Chowdhury. 2012. Amelioration of murineSchistosoma mansoniinduced liver fibrosis by mesenchymal stem cells. Journal of Stem Cell and Regenerative Medicine8: 28–34.
4. Abdel-Rahim, I. M., C. Kaiser, M. A. Homeida, M. Elsheikh, E. Schmidt, J. H. Ehrich, and E. Doehring-Schwerdfeger. 1990. Enzyme activities and protein concentrations in serum of patients with hepatosplenic schistosomiasis. Annals of Tropical Medicine and Parasitology41: 262–264.
5. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly